oseltamivir has been researched along with butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, MC; Courtin, N; Fautrad, P; Fotso, AF; Mas, F; Riteau, B | 1 |
1 other study(ies) available for oseltamivir and butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine
| Article | Year |
|---|---|
Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
Topics: A549 Cells; Animals; Antiviral Agents; Cell Survival; Dogs; Drug Combinations; Female; Gelsolin; Haplorhini; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Madin Darby Canine Kidney Cells; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Oligopeptides; Oseltamivir; Peptide Fragments; Receptors, Formyl Peptide; Receptors, Lipoxin; Sequence Alignment; Virus Replication | 2017 |